Thromboembolic events occurred in 10% of patients receiving epirubicin + cyclophosphamide
- 5 Downloads
KeywordsBreast Cancer High Risk Cyclophosphamide Adjuvant Therapy Deep Vein Thrombosis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International limited or Adis Data Information BV 1996